Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
False
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 5, 2026
6 min read
By choosing where to participate and working with specialist partners, community hospitals can bring more of the CAR T patient journey closer to home
November 4, 2026
9 min read
Stella Vnook explains why broader representation at the investment table can strengthen biotech, expand support for women-led companies, and accelerate innovation in women’s health
November 3, 2026
2 min read
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
November 3, 2026
23 min read
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
False
Affiliations:
Specialties:
Areas of Expertise: